Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
16.44
+1.08 (7.03%)
At close: May 29, 2026, 4:00 PM EDT
16.62
+0.18 (1.12%)
After-hours: May 29, 2026, 7:45 PM EDT
Cullinan Therapeutics Market Cap
Cullinan Therapeutics has a market cap or net worth of $1.01 billion as of May 29, 2026. Its market cap has increased by 140.12% in one year.
Market Cap
1.01B
Enterprise Value
660.87M
1-Year Change
140.12%
Ranking
Category
Stock Price
$16.44
Market Cap Chart
Since the IPO on January 8, 2021, Cullinan Therapeutics's market cap has increased from $829.45M to $1.01B, an increase of 21.81%. That is a compound annual growth rate of 3.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 1.01B | 65.24% |
| Dec 31, 2025 | 611.44M | -13.79% |
| Dec 31, 2024 | 709.21M | 62.69% |
| Dec 29, 2023 | 435.93M | -9.73% |
| Dec 30, 2022 | 482.90M | -28.36% |
| Dec 31, 2021 | 674.05M | -18.74% |
| Jan 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Seaport Therapeutics | 996.92M |
| Lexicon Pharmaceuticals | 981.47M |
| Pharming Group | 971.60M |
| Absci | 947.90M |
| ARS Pharmaceuticals | 933.45M |
| MeiraGTx Holdings | 926.10M |
| Alpha Tau Medical | 913.48M |
| Arbutus Biopharma | 908.67M |